Curadev Pharma Pvt Ltd

Curadev is a clinical-stage drug discovery and development biotechnology company that utilizes a target-centric approach and classical medicinal chemistry to create novel small-molecule therapeutics. The company specializes in identifying and modulating next-generation drug targets in the areas of oncology, immunology, and inflammation, with a focus on innate immunity pathways such as STING (Stimulator of Interferon Genes) and the kynurenine pathway (IDO/TDO). Founded by a team of industry veterans, Curadev has established a successful track record of out-licensing its intellectual property to major global pharmaceutical companies, including Roche, Bayer, and Takeda. The company maintains research laboratories in India and a clinical development subsidiary in the United States, positioning itself as a key bridge between Indian drug discovery capabilities and global clinical development standards.